Coagulation factor viia-jncw (Intravenous)
Medically reviewed by Drugs.com. Last updated on Mar 10, 2022.
ThrombosisSerious arterial and venous thrombotic events may occur following administration of coagulation factor VIIa recombinant-jncw.Discuss the risks and explain the signs and symptoms of thrombotic and thromboembolic events to patients who will receive coagulation factor VIIa (recombinant)-jncw.Monitor patients for signs or symptoms of activation of the coagulation system and for thrombosis .
Commonly used brand name(s)
In the U.S.
- Sevenfact
Available Dosage Forms:
- Powder for Solution
Uses for coagulation factor viia-jncw
Coagulation factor VIIa-jncw is used to treat and prevent bleeding episodes in patients with Hemophilia A or B. Factor VIIa-jncw is a man-made protein produced to replicate the naturally occurring activated factor VII (factor VIIa) in the body. It is used to stop bleeding of injuries for patients with hemophilia by helping the blood to clot.
Coagulation factor viia-jncw is to be given only by or under the direct supervision of your doctor.
Before using coagulation factor viia-jncw
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For coagulation factor viia-jncw, the following should be considered:
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to coagulation factor viia-jncw or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Pediatric
Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of coagulation factor VIIa-jncw in children 12 years of age and older.
Geriatric
Adequate and well-controlled studies have not been done on the relationship of age to the effects of coagulation factor VIIa-jncw in geriatric patients.
Breastfeeding
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Interactions with medicines
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving coagulation factor viia-jncw, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using coagulation factor viia-jncw with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
- Anti-Inhibitor Coagulant Complex
- Factor XIII
- Prothrombin Complex